Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients.

Filgrastim and lack of support of intensive adjuvant chemotherapy for high-risk breast cancer patients. Am J Clin Oncol. 1997 Apr; 20(2):169-72.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.